Skip to main content
Log in

Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

To describe the epidemiology of infection with hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV) among injecting drug users (IDUs) in Australia, in relation to the potential for further spread of HIV in IDUs, a cross-sectional analysis was performed on data from a sample of injecting drug users, correlating markers of exposure to blood-borne viruses with sex, age, sexual orientation, primary current drug injected and duration of injecting in rural and metropolitan Victoria, Australia. The subjects were currently active IDUs from a wide spectrum of age, sex, sexual orientation, geographical location and social background, contacted and recruited through their social networks and from community agencies and prisons by trained peer workers who interviewed and collected blood from them in the field. Sera were tested for antibody to HIV, HCV and hepatitis B core antigen (HBcAg), for hepatitis B surface antigen (HBsAg), and for HCV RNA using reverse transcription and polymerase chain reaction (RT-PCR). At entry to the study, 4.5% (14/311) had antibody to HIV, 47% (146/308) to HBcAg and 68% (206/303) to HCV. Prevalence of HBsAg was 1.8% overall (5/282), and 50% (84/168) were positive for HCV RNA. By multivariate analysis, HIV seropositivity was strongly associated with a history of homosexual contact in males and with exposure to HBV but not to HCV. Those who reported their current primary injected drug to be amphetamines were at greater and continuing risk of HIV infection than were current heroin injectors, while the reverse applied for HCV. The different patterns of exposure to different blood-borne viruses in this particular population of IDUs probably reflects different interactions among different social networks. HCV exposure provides a good surrogate marker for risk behaviour among these IDUs, but HBV exposure provides a better marker for risk of HIV infection. More detailed surveillance strategies for HIV infection, and more targeted HIV prevention programs are necessary to detect and to prevent further spread of HIV in these populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Robert-Guroff M, Weiss S, Giron J, et al. Prevalence of antibodies to HTLV-I, II and III in IV drug abusers from an AIDS endemic area. JAMA 1986; 255: 3133–3137.

    Google Scholar 

  2. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction (editorial review). AIDS 1987; 1: 67–76.

    Google Scholar 

  3. Gust ID. Epidemiology of hepatitis B in Australia. In: Lam SK, Lai CL, Yeoh EK, eds. Viral Hepatitis B Infection. Singapore: World Scientific Publishing, 1984.

    Google Scholar 

  4. Crofts N, Hopper JL, Bowden DS, et al. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237–241.

    Google Scholar 

  5. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug abusers and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375–380.

    Google Scholar 

  6. Whyte BM, Gold J, Dobson AJ, et al. Epidemiology of acquired immunodeficiency syndrome in Australia. Med J Aust 1987; 146: 65–69.

    Google Scholar 

  7. Moaven L, Crofts N, Locarnini SA. Hepatitis C virus infection among Victorian injecting drug users in 1971 (Letter). Med J Aust 1993; 158: 574.

    Google Scholar 

  8. Kaldor J, Elford J, Wodak A, Crofts N, Kidd S. HIV prevalence among IDUs in Australia: a methodological review. Drug Alcohol Rev 1993; 12: 175–184.

    Google Scholar 

  9. Blower S. Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users (Letter). J AIDS 1991; 4: 920–923.

    Google Scholar 

  10. Crofts N, Hay M. Entry of human immunodeficiency virus into injecting drug user populations in Victoria, 1985–89. Med J Aust 1991; 155: 378–382.

    Google Scholar 

  11. Crofts N, Silvester C, Ross M. Absence of HTLV among Australian injecting drug user (Letter). Med J Aust 1992; 157: 70.

    Google Scholar 

  12. Turner CR, Fay RE. Monitoring the spread of the HIV epidemic. In Turner CT, Miller HG, Moses LE, eds. AIDS, Sexual behaviour and intravenous drug use. Washington, DC: National Academy Press, 1989: 447–470.

    Google Scholar 

  13. Van den Hoek JAR, van Haastrecht HJA, Goudsmit J, et al. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823–826.

    Google Scholar 

  14. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from 5′ noncoding region. Japanese J Exp Med 1990; 60: 315–322.

    Google Scholar 

  15. Breslow NE, Day NE. Statistical methods in cancer research. Lyon: International Agency for Research on Cancer, 1980.

    Google Scholar 

  16. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55–68.

    Google Scholar 

  17. Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 1–3.

    Google Scholar 

  18. Evans BG, Catchpole MA, Heptonstall J, et al. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. Br Med J 1993; 306: 426–428.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crofts, N., Hopper, J.L., Milner, R. et al. Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV. Eur J Epidemiol 10, 687–694 (1994). https://doi.org/10.1007/BF01719282

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01719282

Key words

Navigation